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Abstract. In feed production processes, factories usually produce different mixtures within the 
same production line. Consequently, remainders of the first-produced feed can stay in the system 
and be mixed with the following feed charge. This type of transfer (carry-over) is unavoidable 
in the production systems currently used, and thus, non-medicated feed can be contaminated with 
veterinary drugs present in a previously manufactured charge of medicated feed. The carry-over 
of veterinary medicinal products is associated with the risk of residues remaining in the tissues 
of treated animals at the time of slaughter and poses a health hazard to consumers. Producing 
safe feed and food products is, first and foremost, a question of good management practices at 
each stage of the feed and food chain, from primary production to final processing. Primary 
responsibility for feed safety rests with the feed business operator, who must ensure that all 
stages of production, processing and distribution under their control are carried out in accordance 
with relevant legislation, good manufacturing practice and principles contained in the HACCP 
system. Concrete steps for feed manufacturers to prevent drug carry-over are using one or more 
approved cleanout procedures of manufacturing equipment, such as cleaning, flushing or 
sequencing. 
1. Introduction  
The ‘farm-to-fork’ approach promoted by the European Union requires the assessment and control of 
major components of the food production chain, with emphasis on primary production. Feeds must 
satisfy the nutritional requirements of the relevant animal species, and they are expected to support safe 
and cost-effective production of foods of animal origin, as well as to ensure the welfare of farm animals 
[1]. Adequate animal feedingstuffs, which are the main input into livestock production, should be used 
to ensure the final product reaching the market has the required quality and poses no risk to the consumer 
[2]. 
The competitiveness of the agricultural sector because of globalization has led to the need for 
intensified productivity of animal production systems. For this reason, the stocking rate in poultry and 
pig production units was increased, causing a greater frequency of disease due to higher infection 
pressure [3]. Although in recent years much emphasis has been placed on disease prevention through 
improved management and environmental conditions, intensive animal production systems still depend 
on drugs (antimicrobials), as shown by their continuously growing market [4]. A common means to 
deliver such drugs is by including them in feed, as the large-scale use of feedlots makes this easy, and 
as it avoids handling animals for individual drug administration. However, Dunlop et al. [5] and Varga 
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et al. [6] found the use of antimicrobials in feed results in a higher incidence of bacteria resistant to the 
active ingredients, when compared to parenteral treatments.  
Also, the benefit of improved productivity from the use of veterinary medicinal products (VMPs) in 
food producing animals is accompanied by the risk of VMP residues remaining in the tissues of treated 
animals at the time of slaughter or residues in animal-derived products; such residues pose a health 
hazard to consumers. The major public health significances of drug residues are development of 
antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, 
and disruption of normal intestinal microbiota [7]. Currently, microbial antibiotic resistance is 
considered to be one of the greatest threats to human health. In the United States, more than 2 million 
people are infected with antibiotic-resistant bacteria annually, with 23,000 deaths being the direct result 
[8]. 
VMPs are critically needed to meet the challenges of providing adequate amounts of food for the 
growing world population [9], but they should not be used habitually to prevent disease or to compensate 
for poor hygiene or inadequate husbandry conditions. All antibiotics, including those administered in 
feed, must be prescribed by the veterinarian responsible for the animals concerned. In order to conserve 
the effectiveness of antibiotics in the future, it is important that wherever and whenever these medicines 
are used, they are used responsibly: “Use as little as possible and use as much as necessary” [10]. Even 
when feed containing veterinary drugs is prepared following good manufacturing practice guidelines, 
carry-over of active ingredients from previous formulations cannot be ruled out, because most of the 
mixed feed formulations are prepared in multiproduct plants. Carry-over contamination can occur during 
the whole production process [11], with obvious serious consequences. Risk assessment and risk 
management of contaminants in feeds is ultimately a key issue for veterinary public health. 
2. Legal aspects of veterinary drug carry-over in feeds 
After production of medicated feed, it is very difficult to completely avoid carry-over of drugs into feed 
that should be free from such substances (zero tolerance). From the standpoint of legislation, the 
veterinary drug residues in feed are not allowed and their presence, determined during official 
monitoring, excludes the placing of such feed on the market. Currently, this principle applies to eight 
countries within the EU.  
However, there are alternative ways to avoid zero tolerance: direct use of orally-administered drug 
in powder form on the farm, top dressing or administration of drugs via drinking water. Each of these 
methods has certain application risks. Oral powders are usually not dosed into feed by specific, 
calibrated, devices, but are dosed manually by farmers, with evident weaknesses in such a process. The 
use of top dressing methods risk that strong, dominant, animals achieve over-intake, while weaker 
animals with less access to feed achieve lower intake than expected. In such a scenario, the target 
microbial pathogen in an animal is exposed to subtherapeutic dosage of the antimicrobial, so some 
significant number of the target pathogens survives treatment. This induces selection of drug-resistant 
microbial pathogens. The imprecision of delivering drugs via the drinking water system is reflected in 
the amount of water spilled and the variation in the amount of water the animals actually drink. Practical 
drawbacks are the creation of solid complexes in the pipes and obstruction of drinking nipples, which 
affect the precision of drug dosing [12].  
Most countries in the European Union do not have clearly established national limits for unwanted 
carry-over of veterinary drugs in non-target feed, while three countries have established limit values, 
primarily based more on the ALARA values (As Low As Reasonably Achievable), rather than risk 
assessment for public health: 
1. In Belgium, ALARA values are applied, but only under the conditions that the level of cross-
contamination cannot cause: a) animal health disorder; b) exceeded MRL in products of animal origin, 
or; c) increased antimicrobial resistance. In particular, the upper limit values for contamination should 
never be above 2.5% of the minimum prescribed dose for antibiotics or 3% of the maximum prescribed 
dose for antihelmintics. 
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2. In France, validation of the production process is applied: the maximum permitted contamination 
by VMPs is 5% in the first and 1% in the second charge after production of the last medicated feed 
batch. 
3. The legal status in the Netherlands is still in the process of adoption, but the maximum permitted 
contamination in non-target feed will be up to 2.5% of the lowest dose of VMP permitted in the targeted 
feed.  
Stolker et al. [13] have shown that the percentage of veterinary medicine carry-over (in the 
production of medicated feed for pigs in the Netherlands) is not correlated with the percentage 
determined by standard Good Manufacturing Practice (GMP+) procedures. More precisely, it is not 
possible to predict the concentration of antibiotic in a flushing charge based on determined percentage 
of carry-over in the feed production plant. The inability to avoid carry-over, non-homogeneity in the 
production of medicated feed, and the previously stated difficulties in predicting the level of carry-over, 
along with increasing concern about the growing problem of microbial resistance, motivated NEVEDI, 
an association of Dutch feed manufacturers, to announce that they would voluntarily stop the production 
of medicated feed in 2011, which was the first case of this kind in Europe. 
In Serbia, the Rulebook on the Quality of Feed [14] states (in Article 88) that feed mixtures must not 
contain antibiotics or sulphonamides, i.e. zero tolerance is applied, so these substances must not be 
present in feedingstuffs. 
 
3. Legal aspects of carry-over of coccidiostatics and histomonostatics 
In addition to carry-over of veterinary medicines, special attention is required to understand regulatory 
aspects concerning the presence of coccidiostatics and histomonostatics in non-target feed. 
Coccidiostats and histomonostats are substances intended to inhibition the growth or destruction of 
protozoa, and these substances can, inter alia, be approved for use as feed additives in accordance with 
European Regulatory Council Regulation (EC) No 1831/2003[15]. It can be a confusing fact that some 
coccidiostats are registered not as feed additives but as drugs, i.e. VMPs. For active substances in the 
VMP that are the same as a substance in a feed additive, the applicable maximum level of cross-
contamination in non-target feed is the maximum content of feed additive in complete feed established 
in the relevant Union act [16]. A list of the named coccidiostats (registered as VMPs) is given in the 
Annex of Allowed Substances in Commission Regulation No. 37/2010 [17] and consists of Amprolium, 
Decoquinate, Diclazuril, Halofuginone, Imidocarb, Lasalocide and Toltrazuril. As such, they can be 
used in the production of medicated feed, based on veterinary prescription. They are most commonly 
used in the breakthrough of coccidiosis, where no coccidiostatics are added in feed, in cases of 
development of resistance, or when the vaccines are insufficiently efficacious. Carry-over of 
coccidiostatics and histomonostatics can lead to contamination of feed where the use of coccidiostatics 
or histomonostatics is not authorized, such as feed for animal species or categories not specified in the 
authorization of the additive. This inevitable cross-contamination can occur at every stage of production 
and processing of feed, as well as during storage and transport of feed. Inevitable transfer of active 
substances contained in approved coccidiostats and histomonostats into non-target feeds results in the 
presence of undesirable substances in the feed in accordance with Directive 2002/32/EC [18]. Thus, 
taking into account the application of good manufacturing practice, the maximum level of unavoidable 
carry-over should be established according to the ALARA principle. In order to allow the feed producer 
to manage the inevitable transfer, a transfer rate of about 3% (in relation to the maximum allowed 
content) should be taken into account in terms of feed for less sensitive animal species, while for feed 
intended for sensitive non-target species and feed with a withdrawal period, i.e. feed used in the pre-
slaughter period, a transfer rate of about 1% can be considered. A transfer rate of 1% should also be 
established for the cross-contamination of other feed for the target species when it has no added 
coccidiostats and histomonostats, as well as for non-target feed for animals such as dairy cows or layer 
hens, where clear evidence exists of transfer from feed to food of animal origin. In the European Union, 
this described problem is regulated by Commission Directive 2009/8/EC of 10 February 2009 [19]. In 
that Directive, the maximum level of imminent carry-over in non-target feed for 11 coccidiostats has 
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been set: Lasalocid sodium, Narasin, Salinomycin sodium, Monensin sodium, Semumramycin sodium, 
Maduramycin ammonium alpha, Robenidine hydrochloride, Decoquinate, Halofuginone hydrobromide, 
Nicarbazine and Diclazuril. The levels are expressed in mg/kg (ppm) in feed with a moisture content of 
12% (Table 1) and are aimed at avoiding excessive exposure of animals to these compounds, since most 
of the compounds have a relatively low safety margin and their higher concentration in feed can cause 
harmful effects even in the target animal species. In Serbia, in accordance with the harmonization of the 
regulations regarding the animal feed safety sector, in the Rulebook on the Quality of Feed [14], Article 
99 (maximum permissible harmful substances) established identical levels as the EU has for these 
above-mentioned 11 coccidiostats, while the manner of their use and their maximum residue levels in 
food are given in Article 89. When interpreting this Rulebook, it is necessary to note that most 
coccidiostats have been registered as additives only until 2018, so the time limit for placing them on the 
market has already expired. However, other coccidiostats have been registered as additives for longer 
(until 2020, 2021, 2022, 2023, or 2025), and so all these compounds must by carefully selected for use 
in feeds on the basis of their being registered as additives or not. 
 
Table 1. Maximum content levels for coccidiostats in feed as laid down in Commission Directive 
2009/8/EC and Council Regulation 2010/37/EC (Adopted from O’Mahony et al., [20]). 
Feed additive Feed 
dose 
(mg/kg) 
Non-target feed (mg/kg) Withdrawal feed 
(mg/kg) Sensitive Other 
species 
Lasalocid sodium 125 1.25 
D, C, R, E, DA, LB, T > 
12 wks, CL > 16 wks 
3.75 1.25 
CF, CL < 16 wks, T < 
12 wks 
Narasin 70 0.7 
T, R, E, LB, CL > 16 wks 
2.1 0.7 
CF 
Salinomycin 
sodium 
70 0.7 
E, T, LB, CL > 12 wks 
2.1 0.7 
CF, CL < 12 wks, RF 
Monensin sodium 125 1.25 
E, D, SR, Du, B, DC, LB, 
CL, T > 16 wks 
3.75 1.25 
CF, CL, T < 16 wks 
Semduramicin 
sodium 
25 0.25 
LB, CL > 16 wks 
0.75 0.25 
CF 
Maduramicin NH4 
alpha 
5 0.05 
E, R, T, LB, CL > 16 wks 
0.15 0.05 
CF, T < 16 wks 
Robenidine HCl 70 0.7 2.1 0.7 
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LB, CL > 16 wks CF, RFB, T 
Decoquinate 40 0.4 
LB, CL > 16 wks 
1.2 0.4 
CF 
Halofuginone HBr 3 0.03 
LB, CL > 16 wks, T > 12 
wks 
0.09 
Except CL < 
16 wks 
0.03 
CF, T < 12 wks 
Nicarbazin 50 0.5 
E, LB, CL > 16 wks 
1.5 0.5 
CF 
Diclazuril 1 0.01 
LB, CL > 16 wks, TF > 12 
wks 
0.03 
Except CL < 
16 wks, CF, 
TF < 12 wks 
0.01 
RFB 
Key: D = dogs, C = calves, R = rabbits, E = equine, DA = dairy animals, LB = laying birds,  T = turkeys, TF = turkeys for fattening, CL = 
chickens reared for laying, CF = chickens for fattening, RF = rabbits for fattening, RFB = rabbits for fattening and breeding, SR = small 
ruminants (sheep and goats), Du = ducks, B = bovine, DC = dairy cattle. 
4. Risk assessment of carry-over 
The primary responsibility for feed safety rests with the feed business operator, who must ensure that 
all stages of production, processing and distribution under their control are carried out in accordance 
with relevant legislation and good manufacturing practice [21]. The feed producer (commercial or farm) 
is obligated to ensure that the exact amount of the desired drug is correctly incorporated and that there 
is no cross-contamination of any unwanted drug in that feed.  
In feed production processes, factories produce different mixtures within the same production line. 
Consequently, remainders of the first-produced feed can stay in the system and be mixed with the 
following feed charge [19]. This type of transfer is unavoidable in the production systems currently 
used, and thus, non-medicated feed can be contaminated with veterinary drugs present in a previously 
manufactured charge of medicated feed [2]. Carry-over is (usually) expressed as the percentage of the 
nutrient, veterinary medicament and/or contaminant from one feed batch that ends up in the following 
feed batch (flushing charge). Stolker et al. [13] have documented that sometimes a flushing feed is 
contaminated not only with the antibiotic used directly before the production of the flushing feed, but 
also with an antibiotic used several batches earlier in the production process. The same authors pointed 
to the importance of testing the homogeneity of the flushing charge, i.e. determining whether the drug 
is homogeneously distributed in the feed. They found [13] that during the first 20 minutes in the 
production cycle, the flushing charge contained oxytetracycline at concentrations >2.5% of the allowed 
transfer, or significantly higher than the last part of the produced batch. If the flushing charge can be 
easily flushed, the concentration of the contaminant from the previous batch will be very high at the 
beginning and will rapidly fall, but in contrast, in the case of slow flushing, the concentration of the 
given substance will only gradually decrease [22]. These data must be taken into account when taking 
the first kilogram of this type of feed and giving it to a non-target (for the antibiotic-sensitive) animal 
species, as well as possible errors in the interpretation of results if a sample of such feed is sent for 
further analysis. 
The type of drug (category I or II), the number of animal species for which the drug is intended, and 
the feed delivery system determine the degree of risk associated with carry-over. Feed plants producing 
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feed only for one type of animal and using only Category I drugs (which do not have a withdrawal 
period) have the least risk of contamination and the occurrence of residues in tissues of non-target 
animals. Since there is no withdrawal period for these products, they can be used until animals are 
slaughtered, and subsequent animal products can immediately be released to the market. In contrast, 
carry-over of Category II drugs (which have a withdrawal period) into feed could result in the unwanted 
presence of residues in meat, dairy products and eggs of animals. The carry-over of drugs classified as 
either Category I or Category II into a batch of feed intended for a species the drug is not intended for 
can create serious health problems for any such animal consuming the feed [23]. The carry-over of 
Monensin from cattle feed to horse feed which can result in lethal outcomes. The high sensitivity of 
horses to Monensin is associated with their lack of demethylation enzymes, which facilitate the 
clearance of Monensin from the animals’ systems [24]. The U.S. Food and Drug Administration issued 
warning letters in 2018 for two feed mills in Minnesota, and Nebraska that mixed horse feed containing 
monensin. These firms did not adhere to Current Good Manufacturing Practice (CGMP) requirements 
for medicated feed mills. These incidents of monensin toxicity should be a reminder to all feed producers 
that make medicated feeds that they must remain vigilant in adhering to CGMP requirements by 
eliminating unsafe carry-over of medications into feed intended for different species. Guidance for 
Industry # 72 (GMPs for Medicated Feed Manufacturers Not Required to Register and Being Licensed 
with FDA) and Guidance for Industry # 235 (Current Good Manufacturing Practice Requirements for 
Food for Animals) are documents that provide explanation and examples of how to meet the FDA’s 
requirements for safe animal feed production. 
Carry-over can appear in one segment of the production line or can be a result of a combination of 
residues along the whole system [2]. In order to discover the cause of carry-over, all equipment must be 
taken into account, from the place of delivery of the medicine to the loading zone, but carry-over 
occurring during transport or on the farm itself must also be considered. O’Keeffe et al. [25] identified 
multiple potential causes for the presence of coccidiostat (Nicarbazine) residues in edible livestock 
tissues: contamination of feed in mixtures and/or during transport, supply of wrong feed, delivery of 
feed to the wrong bin on the farm, inadequate cleaning of the feeding system on farms before delivery 
of replacement feed, inadequately applied withdrawal period for feed with coccidiostatics, poor farm 
management that led to re-exposure of poultry to Nicarbazine in the period immediately prior to 
slaughter, and fecal recycling of Nicarbazine from the litter. McEvoy et al. [26] also pointed to the 
importance of particles of dust and excess material remaining during the pelleting process as an 
important factor in carry-over. The production practice at one factory was such that material returned to 
pre-press and contaminated the next production lot [26]. The most important sources of carry-over, 
related to production equipment, are summarized in Table 2. In Good Manufacturing Practice guidance 
[27], the main causes of carry-over are the dosing/grinding/mixing line, the press line, and the 
measurement stations within the lines. This type of carry-over is termed installation carry-over. 
 
Table 2. Sources of carry-over regarding feed plant equipment (Adopted from Harner et al., [23]) 
Equipment Mode of Carry-over 
Dust system 
-delayed return of dust to production line 
-excessive pickup of drug and carrier 
-hang-up (electrostatic or moisture) 
Mixer -residual feed remaining in mixer 
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-buildup of material on ribbons and walls 
-electrostatic hang-up on walls and top 
-leaking mixer gate (not fully closed) 
Surge bin 
-incomplete clean-out 
-electrostatic or moisture hang-up 
Conveyors -same as surge bin 
Elevators 
-residual feed remaining in buckets and boot 
-electrostatic or moisture hang-up 
Bins 
-bridging 
-residual feed from incomplete cleanout 
Bulk truck 
-error in bin chart records 
-incomplete clean-out 
-bridging and hang-up 
 
5. Risk management of carry-over 
When the sources of carry-over are revealed, corrective measures can be taken. The basic principles that 
feed business operators should establish, implement and maintain [21] are contained in the HACCP 
system. HACCP principles are largely limited to the ability to carry out the following: 
(a) Identify any hazards that must be prevented, eliminated or reduced to acceptable levels; 
(b) Identify the critical control points at the step or steps at which the control is essential to prevent 
or eliminate a hazard or reduce it to acceptable levels; 
(c) Establish critical limits at critical control points which separate the acceptability from 
unacceptability, for the prevention, elimination or reduction of identified hazards; 
(d) Establish and implement effective monitoring procedures at critical control points; 
(e) Establish corrective action when monitoring indicates that a critical control point is not under 
control; 
(f) Establish procedures to verify that the measures outlined in points (a) to (e) are complete and 
effective. Verification procedures will be carried out regularly; 
(g) Establish documents and records commensurate with the nature and size of the feed business to 
demonstrate the effective application of the measures set out in points (a) to (f). 
HACCP principles can help feed business operators to achieve a higher standard of feed safety, but 
should not be considered as a method of self-regulation and do not replace official controls. Each plant 
must establish its own rules and manage carry-over based on their own HACCP program. Although 
most feed businesses are familiar with ISO 9000, it focuses on systems and procedures. However, 
HACCP is different, as it focuses on the product. ISO 9000 and similar standards are not an essential 
requirement for successful HACCP programs [28]. 
Concrete steps for feed manufacturers to prevent drug carry-over are set by CGMP requirements, 
and they are involve using one or more approved cleanout procedures for the manufacturing equipment, 
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such as cleaning, sequencing and/or flushing [29]. The FDA’s CGMP requirements serve as guidelines 
for medicated feed manufacturers to ensure that their products meet identity, strength, and quality 
standards. 
5.1. Cleaning the equipment 
Equipment cleaning is still not widespread in the feed manufacturing industry, but it is potentially the 
most effective method of avoiding carry-over during processing and delivery of feed. It is mainly applied 
in high risk situations: dealing with medical premixes; when sequencing can not be included in the 
production schedule; with portable grinder-mixers; when the physical properties of the drug are such 
(adhesion strength and electrostatic properties) that sequencing and flushing do not prevent carry-over, 
and; if liquid ingredients (molasses or fat) are added during the feed mixture production [23]. In all of 
these cases, physically cleaning the production equipment (cleaning of the mixer, transport system, 
pellet coolers, bins) or delivery trucks is required. This involves completely stopping production, which 
is impractical and economically burdensome for the factory. However, GMP stipulates that all 
equipment should be designed, constructed, installed and maintained in such a way as to facilitate the 
inspection and use of cleaning procedures. In terms of cleaning efficiency, horizontal mixers have an 
advantage over vertical ones. A typical cross-section of a double-ribbon horizontal mixer is shown in 
Figure 1. When the mixer has been emptied, the residual feed will remain in the space between the outer 
ribbon and the housing. Some mixers can be adjusted to reduce this space to about 6 mm, which reduces 
the feed carry-over to an innocuous level in most cases. A typical single screw vertical mixer is shown 
in Figure 2, along with the location of the mixer discharge. A considerable amount of feed will remain 
in the mixer after the last feed leaves the discharge opening. If a clean-out opening is provided down on 
the boot of the mixer, the residual feed can be removed there. If it is not removed, a significant amount 
(18 kilos or more) of carry-over can pass into the following feed charge [30]. Some plants clean their 
equipment routinely, e.g. at monthly or bi-annual levels. When employees perform cleaning tasks, it is 
important to remove all waste and residues before the next production cycle, use safe and approved 
cleaning agents, use safe and clean tools, pay attention to the hygiene of the personnel involved in the 
task, and ensure that washing does not disseminate microbial or other contaminants in the equipment. 
After cleaning, inspection should safely review all available parts of production line (such as mixers, 
containers, conveyors, etc.) to ensure they are clean and that carry-over will not occur. Inspection should 
be carried out visually, without entering the mixer or bin [31]. 
 
Figure 1. Double ribbon horizontal mixer                       Figure 2. Single screw vertical mixer        (Adopted 
from Wilcox et al., [30])                                           (Adopted from Wilcox et al., [30]) 
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5.2. System flushing 
The flushing procedure involves passing a precise amount of a selected ingredient through the system 
to flush through any residual medicated feed produced in the previous batch. As a flushing material, 
grain meals are often used, most commonly ground corn of approximately 600 microns. Other suitable 
material that has been proven to adequately clean the production line can be used [23, 32], as can wheat 
[28], limestone [31], and rice hulls [33]. When material passes through the production system, it is mixed 
with the residual medicated feed from the previous batch, and dilutes the drug concentration to a safe 
level. The quantity of flushing material depends on the system; it usually amounts to about 5-10% of 
the mixer capacity and should not be less than 90 kilograms [23]. Some tests have shown that flushing 
material amounting to 1-2.5% of the mixer capacity can be effective in preventing carry-over [32]. Also, 
the plant should check with mixer’s manufacturer for their recommendation for flushing material type, 
and choose the best option. Due to the degree of variability among facilities, feedmills should determine 
their facility’s individual characteristics and apply appropriate time and volume requirements for 
flushing material to accomplish the intent of the procedures. The volume used should be stated in the 
written procedures, and should be based on documented analysis or tests of the firm’s system [31]. 
After the flushing material is added to the mixer, the mixer should be allowed to operate for at least 
1 minute before the material is removed. After the mixer is flushed, the material should pass through the 
whole production system along the same pathway the previously manufactured medicated feed passed. 
The flushing material, from that moment, must be correctly identified and stored in order to prevent 
contamination, and later it can be used in the production of the same medicated feed. Some plants use 
this flushing material to flush trucks for bulk deliveries after they make deliveries to the farm. When 
applying these procedures, the economic implications of the need to store the flushing material should 
be taken into account. Some companies choose to simply discard this material in order to avoid 
subsequent possible production errors, which is certainly the economically least attractive option. 
Manufacturers must document the applicable flushing procedures: the flushing method, the flushing 
time, the amount and type of flushing material and the disposal of the flushing material.  
To monitor flushing, inspection must ensure that feed producers adequately apply their own 
procedures. It is necessary to check that the entire system is flushed (including mixer, conveyors, bins) 
and to visually determine whether any foreign material is not in accordance with the flushing material. 
Finally, quantity of flushing material released into the system must be present at the end of the flushing 
process [31]. 
5.3. Sequencing procedure 
The feed industry most often uses sequencing because it minimizes discontinuation of the production 
line. If properly planned and executed, this method is the most cost-effective carry-over prevention 
procedure. The order in which the feed is prepared, processed and delivered directly determines the 
probability of carrying over the drug from one to the next batch and, consequently, the presence of 
residues in the tissues of the animals that consume such feed. This work plan involves production of all 
medicated feeds that contain the same drug in the sequence from the highest to the lowest level of the 
drug. After completion of the last batch of medicated feed, the production of non-medicated feed for the 
same animal species continues. 
Examples of accepted principles to be considered when designing the sequencing process [34] are: 
• Withdrawal feed and feed for cattle should not be produced and processed in the same equipment 
after the manufacture of medicated feed containing Category II drugs, unless appropriate cleaning 
procedures are applied. Drugs with specific toxicity characteristics, such as Monensin’s toxicity for 
horses, require special attention. 
• After the production of medicated feed containing Category II drugs, feed for the same species that 
are below the marketable age or weight may be produced. 
• Feeds that have high potential for dangerous drug contamination (feed for withdrawal, dairy 
animals, etc.) should be produced first in the series, and feed with the most toxic drugs will be the last 
in the sequencing process, followed by complete physical cleaning of the system . 
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• Sequencing procedures and practices should be clearly understood by all persons responsible for 
the planning and production of medicated feed. They should be easily accessible for their use. 
During the sequencing of feed, the age of the animal, the sensitivity to the administered drug, and 
the type and purpose of the drug should be considered. For example, after production of medicated feed 
containing oxytetracycline for broilers, non-medicated feed for layers should not be produced. Given 
that a very small amount of sulfamethazine consumed by pigs can lead to residues of this drug in meat, 
it is not acceptable to manufacture feed for pigs after the production of medicated feed with 
sulfamethazine [29]. Feed for pigs containing Carbodox should not be followed by unmedicated feed 
for gravid sows. After production of Monensin-containing feed, only non-medicated feed for cattle, 
poultry, or pigs can follow, but not feed for horses. If feed is produced for only one type of animal, such 
as pigs, the most common medicated feed is for the youngest, most vulnerable category, in this case 
piglets. In this case, the following order is applied: first, feed containing a drug that requires a withdrawal 
period for piglets, then sow, grower and finally, finisher feed. Sequencing can also be used to clean 
containers on trucks, but the same principles should be followed. In most feed factories, feed sequencing 
procedures will reduce carry-over to a level that eliminates the potential for the presence of residues in 
animal tissue. However, the sequencing procedure cannot reduce carry-over to a sufficiently low level 
unless the problems listed in Table 2 have been previously resolved. When sequencing is applied, in 
order to avoid cross-contamination, precise records of feed production documentation are imperative, 
so the last batch in a series can always be safely marked. Otherwise, the sequencing procedure could be 
compromised by the next feed charge preparation. Periodic evaluation of sequencing procedure should 
be carried out to verify and validate their effectiveness [27, 28, 31]. 
After the application of the described cleaning procedures, if the undesired carry-over of critical 
additives and VMPs can still be expected, then the company could take up the following measures: draw 
up a mandatory production (working) sequence; additional measures in the event of product changes; 
produce feeds with critical additives and VMPs on another line; switch to less critical agents [27]. When 
carry-over is detected in a feed plant, harmful effects can occur in people and in animals that consume 
contaminated feed. This type of failure is considered a violation of the regulations, with all consequences 
for the responsible persons. Based on the Rules on the Establishment of the Feed Safety Monitoring 
Program for 2018 [35], in Serbia, if the presence of contaminants in feed is detected, activities ranging 
from corrective measures to prohibition of operation and closure of the entire feed production facility 
will be implemented.  
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